Welcome to
On Feet Nation
India's first mRNA-based Covid-19 vaccine candidate HGCO19 by Gennova Biopharmaceuticals Ltd has been granted approval for phase 2/3 clinical trails, the department of biotechnology (DBT) said on Tuesday. The Pune-based biotechnology company had submitted the interim clinical data of the vaccine’s phase 1 study to the central drugs standard control organisation, it said.
https://health.economictimes.indiatimes.com/news/pharma/gennova-vax...
© 2024 Created by PH the vintage.
Powered by
You need to be a member of On Feet Nation to add comments!
Join On Feet Nation